Synageva BioPharma Corp (NASDAQ:GEVA)

99.54
Delayed Data
As of Mar 30
 +0.84 / +0.86%
Today’s Change
60.19
Today|||52-Week Range
122.88
+7.27%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Operating ActivitiesNet Income / Starting Line-36.4M-50.2M-48.3M-57.7M
 
 
 
 
 
Depreciation1.4M1.7M1.3M1.6M
 
 
 
 
 
Total Other Cash Flow3.9M5.2M7.9M11.3M
 
 
 
 
 
Funds From Operations-31.1M-43.3M-39.1M-44.8M
 
 
 
 
 
Funds From/For Other Operating Expenses2.9M-7.7M998.0K-4.4M
 
 
 
 
 
Net Cash Flow - Operating Activities-34.0M-35.6M-40.1M-40.4M
 
 
 
 
 
 
InvestingIncrease In Investments-167.6M-141.3M-109.3M-96.2M
 
 
 
 
 
Decrease In Investments90.7M95.1M160.5M140.5M
 
 
 
 
 
Capital Expenditures-3.2M-5.6M-5.2M-2.7M
 
 
 
 
 
Other Investing - Uses0.000.00-216.0K0.00
 
 
Other Investing - Sources320.0K0.00-320.0K0.00
 
 
 
Net Cash Flow Investing-79.9M-51.9M45.5M41.6M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.00----
Long Term Debt Reduction0.000.000.00----
Net Proceeds Stock Sale204.1M5.6M884.0K5.0M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.0095.0K78.0K
 
 
 
Net Cash Flow - Financing204.1M5.6M789.0K4.9M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-5.0K-13.0K-54.0K-34.0K
 
 
 
 
 
 
Net Change In Cash90.2M-81.9M6.1M6.2M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account